<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>KYUNG HEE UNIV.</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJEB9433</full_dataset_link><long_description>The present study used 16S rRNA gene-based pyrosequencing to examine whether differential regulation of mechanistic target of rapamycin (mTOR) signaling induced by diet (a high-fat diet [HFD] or normal-chow diet [NCD]) and/or therapeutics (resveratrol [a specific inhibitor of mTOR complex 1] and/or rapamycin [an inhibitor of both mTOR complex 1 and 2]) altered the composition of the gut microbiota in mice.</long_description><repository>ENA</repository><description_synonyms>digestive canal, Microbial Community Composition, LCATA deficiency, Antibiotic AY 22989, Bowel, Laboratory, 18R, 35-hexamethyl-11, Mus domesticus, trans-Resveratrol-3-O-sulfate, enteric tract, House Mouse, trans Resveratrol, 10, Human, titanio, alpha-lecithin:cholesterol acyltransferase deficiency, 14, Gus, Gur, 17, Gut, titane, House, 19R, 18-dihydroxy-12-{(2S)-1-[(1S, Mus musculus domesticus, 1, 23S, 3, 5, cis Resveratrol, Mice, 9S, Titan, Partial LCAT deficiency, dyslipoproteinemic corneal dystrophy, 21, 23, 24, 24E, 26, 5-Stilbenetriol, gut, 29, rapamycin., 35R)-1, Swiss, SRT501, AY 22-989, 9)]hexatriaconta-16, Microbial Community Structure, alimentary tract, 12S, Swiss Mice, 3-Benzenediol, FED, 20-pentone, g, (1R, SRT 501, Microbial Community Structures, fish-eye disease, digestive tube, asd, 4', house mouse, adult alimentary canal, alimentary system, AY 22989, intestines, Human Microbiome, 3R, 26E, 5-((E)-2-(4-hydroxyphenyl)ethenyl)-, Community Composition, AY 22 989, mouse, Ti, 30S, Microbial, alpha-lecithin cholesterol acyltransferase deficiency, mice C57BL/6xCBA/CaJ hybrid, Mus muscaris, Resveratrol 3 sulfate, (-)-Rapamycin, gut tube, Resveratrol-3-sulfate, Mus, Rapamycin, I2190A, 15R, I-2190A, sirolimusum, SRT-501, 30-dimethoxy-15, alimentary canal, Microbial Communities, Microbiome, 28E, 16E, 22Ti, Mus musculus, AI747421, (Z)-, titanium, Microbiomes, Microbial Community Compositions, 4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19, Microbial Community, alpha-LCAT deficiency, mice, I 2190A, Swiss Mouse, Gus-u, Community Structure, Gus-t, 28-tetraene-2, Gus-s, 32S, Gus-r, House Mice, Resveratrol, sirolimus, Rapamune, domesticus, Laboratory Mice, 5-Trihydroxystilbene, Composition, 4'-Trihydroxystilbene, gastrointestinal system, trans Resveratrol 3 O sulfate, 36-dioxa-4-azatricyclo[30.3.1.0(4, cis-Resveratrol, Microbiotas, 21R, Mouse, trans-Resveratrol, Laboratory Mouse, Human Microbiomes, Community</description_synonyms></additional><is_claimable>false</is_claimable><name></name><description>454 FLX titanium seqeunces of gut microbiota of NCD or HFD fed mouse treated with resveratrol or rapamycin</description><dates><last_updated>2016-05-20</last_updated><first_public>2016-09-01</first_public></dates><accession>PRJEB9433</accession><cross_references/></HashMap>